Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Chiral Alcohol. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN107021884A reveals high-efficiency Ir/f-amphox catalysis for chiral 1,2-amino alcohols, offering superior TON and enantioselectivity for pharmaceutical manufacturing.
Patent CN121065123A reveals enhanced enzyme stability for chiral alcohol manufacturing cost reduction and supply reliability.
Patent CN100344766C details a cost-effective enzymatic resolution of 2-methyl-1-butanol using vinyl acetate, offering significant supply chain advantages for pharmaceutical intermediates.
Novel carbonyl reductase mutants enhance thermal stability and yield for pharmaceutical intermediates like florfenicol and statins, offering cost-effective biocatalytic solutions.
Patent CN104418775B details palladium-catalyzed asymmetric hydrogenolysis for high-purity chiral amine production offering significant supply chain and cost advantages.
Patent CN101085990A reveals chemo-enzymatic route for high-purity chiral alcohols. Enables cost reduction and supply chain reliability for pharmaceutical intermediates.
Analysis of patent CN101085990B reveals a chemo-enzymatic route for high-purity chiral alcohols. This method offers significant supply chain stability and cost reduction advantages for pharmaceutical intermediate manufacturing.
Patent CN108359649A reveals high-selectivity alcohol dehydrogenase mutants for synthesizing chiral biaryl alcohols, offering cost reduction and supply reliability.
Patent CN114836486B details a novel monooxygenase method for synthesizing chiral beta-amino alcohols, offering significant cost reduction and supply chain reliability for pharmaceutical intermediates.
Patent CN102154377B reveals ScCR enzyme for asymmetric reduction. Enables cost-effective manufacturing of pharmaceutical intermediates with self-regenerating cofactors.
Patent CN112852771A details enzymatic synthesis of chiral amino alcohols using imine reductase, offering high stereoselectivity and mild conditions for pharmaceutical manufacturing.
Patent CN1257468A reveals novel Cp*-metal catalysts for efficient asymmetric transfer hydrogenation, offering significant cost reduction in pharmaceutical manufacturing and safer processing.
Patent CN115093323B enables efficient iridium-catalyzed synthesis of beta-functionalized chiral homoallylic alcohols. Delivers high enantioselectivity and scalable pharmaceutical intermediate manufacturing solutions.
Patent CN104232696A reveals biocatalytic method for high-purity chiral alcohol. Offers cost reduction and supply chain reliability for pharmaceutical manufacturing.
Patent CN108570460B discloses novel SDR mutants enabling high-selectivity biocatalytic reduction of acetophenone derivatives, offering a greener alternative for pharmaceutical intermediate manufacturing.
Novel carbonyl reductase mutants enhance chiral alcohol synthesis yield and stability for pharmaceutical manufacturing supply chains ensuring reliable high-purity intermediate sourcing.
Patent CN103044193B reveals a room-temperature zinc-catalyzed method for chiral secondary alcohols, offering significant cost and supply chain advantages for pharmaceutical manufacturing.
Patent CN101052604A details a catalytic de-enrichment method for chiral substrates, offering cost-effective recycling of unwanted isomers for pharmaceutical intermediate manufacturing.
Patent CN1622932A details a novel ruthenium catalyst for efficient chiral alcohol resolution. Enables cost reduction in pharmaceutical manufacturing via simplified purification.
Discover the advanced catalytic synthesis of chiral heterocyclic tertiary alcohol intermediates. Enhance yield and purity for antihypertensive API manufacturing with our scalable solutions.